These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 29680218)
1. Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease: 5-Year Clinical Outcomes of the Prospective Randomized Pilot Study. Tajstra M; Hrapkowicz T; Hawranek M; Filipiak K; Gierlotka M; Zembala M; Gąsior M; Zembala MO; JACC Cardiovasc Interv; 2018 May; 11(9):847-852. PubMed ID: 29680218 [TBL] [Abstract][Full Text] [Related]
2. Hybrid revascularization for multivessel coronary artery disease. Gąsior M; Zembala MO; Tajstra M; Filipiak K; Gierlotka M; Hrapkowicz T; Hawranek M; Poloński L; Zembala M; JACC Cardiovasc Interv; 2014 Nov; 7(11):1277-83. PubMed ID: 25459040 [TBL] [Abstract][Full Text] [Related]
3. Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis. Sardar P; Kundu A; Bischoff M; Chatterjee S; Owan T; Nairooz R; Giri J; Halkos ME; Liberman H; Douglas JS; Mukherjee D Catheter Cardiovasc Interv; 2018 Feb; 91(2):203-212. PubMed ID: 28471093 [TBL] [Abstract][Full Text] [Related]
4. Hybrid Coronary Revascularization Versus Conventional Coronary Artery Bypass Surgery: Utilization and Comparative Outcomes. Hannan EL; Wu Y; Cozzens K; Sundt TM; Girardi L; Chikwe J; Wechsler A; Smith CR; Gold JP; Lahey SJ; Jordan D Circ Cardiovasc Interv; 2020 Oct; 13(10):e009386. PubMed ID: 33040581 [TBL] [Abstract][Full Text] [Related]
6. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199 [TBL] [Abstract][Full Text] [Related]
7. Randomized Clinical Trial of Hybrid vs. Surgical vs. Percutaneous Multivessel Coronary Revascularization: 5‑year Follow-up of HREVS Trial. Ganyukov VI; Kochergin NA; Shilov AA; Tarasov RS; Kozyrin KA; Prokudina ES; Barbarash OL; Barbarash LS Kardiologiia; 2023 Dec; 63(11):57-63. PubMed ID: 38088113 [TBL] [Abstract][Full Text] [Related]
8. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years. Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA; JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201 [TBL] [Abstract][Full Text] [Related]
9. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. Harskamp RE; Puskas JD; Tijssen JG; Walker PF; Liberman HA; Lopes RD; Vassiliades TA; Peterson ED; Halkos ME Am J Cardiol; 2014 Jul; 114(2):224-9. PubMed ID: 24878119 [TBL] [Abstract][Full Text] [Related]
19. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906 [TBL] [Abstract][Full Text] [Related]
20. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial. Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]